Latin American research indicates a lower prevalence of a type of head and neck cancer

Squamous cell carcinoma is one of the most common and aggressive types of cancer in the head and neck region. It is the fifth ...
mskcc.org

Tumor Hypoxia: A Clinical Biomarker of Distant Metastasis Risk after Chemoradiotherapy for Head and Neck Cancer

Tumor hypoxia on 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) may serve as a reliable clinical biomarker of distant metastasis risk for patients with head and neck squamous cell ...

Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

(ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR ...
Nature

Esophageal Cancer in Head and Neck Squamous Cell Carcinoma

Esophageal cancer occurring in patients with head and neck squamous cell carcinoma (HNSCC) represents a critical clinical challenge, as these secondary tumours notably worsen patient prognosis. Owing ...
Healio

Adjuvant nivolumab improves DFS in high-risk head and neck cancer

Please provide your email address to receive an email when new articles are posted on . Patients who received nivolumab had longer DFS than those who received standard care. OS will be evaluated after ...
Medscape

New Standard of Care in Locally Advanced Head and Neck Cancer?

Adding neoadjuvant and adjuvant pembrolizumab to the standard of care significantly improved event-free survival in patients with previously untreated, locally advanced head and neck squamous cell ...
Namibian Sun on MSN

The hidden face of cancer in Namibia: Understanding head and neck squamous cell carcinoma

HPV is the most common viral sexually transmitted infection. Linda Ratjama In a country where preventable diseases still claim too many lives, a new silent threat is slowly emerging: Head and neck ...